| Primary |
| Hypertension |
23.1% |
| Acute Coronary Syndrome |
19.5% |
| Prophylaxis |
11.7% |
| Hyperlipidaemia |
9.3% |
| Diabetes Mellitus |
5.5% |
| Coronary Artery Disease |
4.5% |
| Antiplatelet Therapy |
3.7% |
| Angina Pectoris |
3.3% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Acute Myocardial Infarction |
2.9% |
| Product Used For Unknown Indication |
2.6% |
| Cardiac Failure |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Anticoagulant Therapy |
1.4% |
| Blood Cholesterol |
1.3% |
| Depression |
1.2% |
| Dyslipidaemia |
1.1% |
| Blood Pressure |
1.0% |
| Haemorrhoidal Haemorrhage |
0.9% |
| Diuretic Therapy |
0.9% |
|
| Chest Pain |
14.2% |
| Hospitalisation |
14.2% |
| Angina Pectoris |
12.3% |
| Myocardial Infarction |
8.7% |
| Acute Myocardial Infarction |
6.3% |
| Thrombosis In Device |
6.3% |
| Angina Unstable |
4.5% |
| Cardiac Tamponade |
3.6% |
| Death |
3.0% |
| Syncope |
3.0% |
| Abdominal Pain |
2.7% |
| Cardiac Failure Congestive |
2.7% |
| Cerebrovascular Accident |
2.7% |
| Non-cardiac Chest Pain |
2.7% |
| Pneumonia |
2.7% |
| Palpitations |
2.4% |
| In-stent Coronary Artery Restenosis |
2.1% |
| Ventricular Fibrillation |
2.1% |
| Cardiac Failure |
1.8% |
| Myocardial Ischaemia |
1.8% |
|
| Secondary |
| Hypertension |
25.0% |
| Acute Coronary Syndrome |
16.9% |
| Hyperlipidaemia |
9.5% |
| Coronary Artery Disease |
9.0% |
| Antiplatelet Therapy |
4.4% |
| Prophylaxis |
4.4% |
| Diabetes Mellitus |
4.3% |
| Acute Myocardial Infarction |
3.9% |
| Gastrooesophageal Reflux Disease |
3.5% |
| Angina Pectoris |
3.0% |
| Product Used For Unknown Indication |
2.5% |
| Haemorrhoidal Haemorrhage |
1.9% |
| Blood Cholesterol |
1.8% |
| Pain |
1.7% |
| Type 1 Diabetes Mellitus |
1.7% |
| Anticoagulant Therapy |
1.6% |
| Hypercholesterolaemia |
1.5% |
| Depression |
1.4% |
| Dyslipidaemia |
1.1% |
| Blood Pressure |
1.1% |
|
| Angina Pectoris |
16.2% |
| Chest Pain |
13.4% |
| Acute Myocardial Infarction |
7.7% |
| Myocardial Infarction |
5.6% |
| Abdominal Pain |
4.9% |
| Cardiac Tamponade |
4.9% |
| Thrombosis In Device |
4.9% |
| Hypersensitivity |
4.2% |
| Ileus Paralytic |
4.2% |
| Peripheral Arterial Occlusive Disease |
4.2% |
| In-stent Coronary Artery Restenosis |
3.5% |
| Non-cardiac Chest Pain |
3.5% |
| Palpitations |
3.5% |
| Upper Gastrointestinal Haemorrhage |
3.5% |
| Adverse Event |
2.8% |
| Cardio-respiratory Arrest |
2.8% |
| Renal Failure |
2.8% |
| Syncope |
2.8% |
| Cardiogenic Shock |
2.1% |
| Cerebrovascular Accident |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.3% |
| Medical Diet |
19.0% |
| Neoplasm |
11.2% |
| Diabetes Mellitus |
8.1% |
| Coronary Artery Disease |
6.1% |
| Back Pain |
5.4% |
| Flatulence |
5.4% |
| Stomatitis |
4.4% |
| Diarrhoea |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Hypercholesterolaemia |
2.7% |
| Hypothyroidism |
2.7% |
| Pulmonary Embolism |
2.7% |
| Deep Vein Thrombosis |
2.4% |
| Acute Myocardial Infarction |
0.7% |
| Angina Pectoris |
0.7% |
| Chest Pain |
0.7% |
| Drug Use For Unknown Indication |
0.7% |
| Migraine |
0.7% |
| Myocardial Infarction |
0.7% |
|
| Pyrexia |
34.8% |
| Electrolyte Imbalance |
8.7% |
| Haemorrhage Intracranial |
8.7% |
| Rhabdomyolysis |
8.7% |
| Arthralgia |
4.3% |
| Blood Creatine Phosphokinase Increased |
4.3% |
| Cerebral Haematoma |
4.3% |
| Hypoglycaemia |
4.3% |
| Mobility Decreased |
4.3% |
| Muscle Spasms |
4.3% |
| Myocardial Infarction |
4.3% |
| Oedema Peripheral |
4.3% |
| Ulcer Haemorrhage |
4.3% |
|
| Interacting |
| Myocardial Infarction |
66.7% |
| Acute Myocardial Infarction |
33.3% |
|
|
